KYUNG NAM PHARM.CO.,LTD. Logo

KYUNG NAM PHARM.CO.,LTD.

South Korean maker of OTC medicines, health foods, and cosmetics, known for its Lemona Vitamin C.

053950 | KO

Overview

Corporate Details

ISIN(s):
KR7053950002
LEI:
Country:
South Korea
Address:
경상남도 의령군 동동리 1539-5, 의령군
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1957, Kyung Nam Pharm Co., Ltd. is a South Korean pharmaceutical company specializing in the manufacturing and sale of over-the-counter (OTC) medicines, health functional foods, and cosmetics. The company is renowned for its flagship brand, Lemona, which was introduced in 1983 as the country's first powdered Vitamin C and has since become a leading product in the vitamin and inner-beauty markets. Its portfolio also includes well-known OTC products such as 'PM' for athlete's foot and 'Minol F Troche' for sore throats. Kyung Nam Pharm is also a prominent manufacturer of human placenta-based medicines, reinforcing its long-standing focus on consumer health and wellness.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-10 00:00
Share Issue/Capital Change
전환가액의조정
Korean 22.8 KB
2025-08-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 87.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-11 00:00
Share Issue/Capital Change
전환가액의조정
Korean 22.0 KB
2025-07-10 00:00
Share Issue/Capital Change
전환가액의조정
Korean 21.6 KB
2025-06-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 97.1 KB
2025-06-23 00:00
Share Issue/Capital Change
전환가액의조정
Korean 14.4 KB
2025-06-10 00:00
Share Issue/Capital Change
전환가액의조정
Korean 21.1 KB
2025-05-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 87.6 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-12 00:00
Share Issue/Capital Change
전환가액의조정
Korean 20.7 KB
2025-04-10 00:00
Share Issue/Capital Change
전환가액의조정
Korean 20.7 KB
2025-03-20 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.9 KB
2025-03-12 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 581.0 KB
2025-03-10 00:00
Share Issue/Capital Change
전환가액의조정
Korean 20.3 KB

Automate Your Workflow. Get a real-time feed of all KYUNG NAM PHARM.CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KYUNG NAM PHARM.CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KYUNG NAM PHARM.CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MADRIGAL PHARMACEUTICALS, INC. Logo
Develops and delivers the first FDA-approved treatment for the liver disease MASH.
United States of America
MDGL
Magle Chemoswed Holding AB Logo
A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.
Sweden
MAGLE
Develops at-home diagnostic tests for the early detection of life-threatening cancers.
Germany
MYNZ
MANNKIND CORP Logo
Develops inhaled therapies for endocrine, orphan lung, and cardiometabolic diseases.
United States of America
MNKD
MARAVAI LIFESCIENCES HOLDINGS, INC. Logo
Provides nucleic acid products and biologics safety testing for new therapies and vaccines.
United States of America
MRVI
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria
MARI
Marker Therapeutics, Inc. Logo
Developing non-genetically modified T cell immunotherapies for hematologic and solid tumors.
United States of America
MRKR
Matinas BioPharma Holdings, Inc. Logo
Developing oral drugs via a lipid nano-crystal platform for infections, oncology & inflammation.
United States of America
MTNB
Matricelf Ltd. Logo
Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.
Israel
MTLF
Maze Therapeutics, Inc. Logo
Develops genetic precision medicines for common diseases, with a focus on chronic kidney disease.
United States of America
MAZE

Talk to a Data Expert

Have a question? We'll get back to you promptly.